Home LiteratureArticle Details
PMID: 7395964 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

A differential effect of C5a and C5a des Arg in the induction of pulmonary inflammation.

The American journal of pathology ·Vol. 100 ·No. 1 ·1980-07-00 ·Pages 179-92

Larsen GL, McCarthy K, Webster RO, Henson J, Henson PM

Abstract

Earlier studies have shown that C5 fragments induce an inflammatory reaction when instilled into the rabbit lung. Because C5a is rapidly converted to C5a des Arg in vivo, experiments were performed to determine which fragment was most effective in producing pulmonary inflammation in this animal model. C5a des Arg consistently produced marked inflammation. This was characterized by neutrophil accumulation, edema, hemorrhage, fibrin formation, and damage to alveolar epithelium. The time course of the inflammatory reaction initiated by C5a des Arg showed pulmonary vascular sequestration of neutrophils with no intra-alveolar migration at 30 minutes after injection. By 2 hours, interstitial and alveolar neutrophils were numerous, with the accumulation of neutrophils in the alveoli increasing to a maximum at 6 hours. At 24 and 48 hours, the predominant cells were mononuclear (macrophages). By 120 hours, the lesions were resolving. In contrast, at all doses examined, a similar instillation of C5a induced either no inflammation or a milder, more focal response than C5a des Arg. This inability of C5a to initiate inflammation was not apparently due to the generation of inhibitors, since mixtures of C5a and C5a des Arg were phlogistic. A prolonged, intrapulmonary infusion of C5a (20 minutes), in contrast to a bolus instillation (1 minute), did initiate an inflammatory response, which may reflect the conversion of the C5a to C5a des Arg in the lung. This study points out the inflammatory potential of products of complement activation, particularly of the C5 fragment C5a des Arg, when applied to the airway side of the lungs. This inflammatory response raises the possibility that cleavage of intrapulmonary C5 may play an important role in the initiation of pulmonary inflammation.

MeSH Terms
Anaphylatoxins/administration & dosage,metabolism,pharmacology Animals Complement C5/administration & dosage,metabolism Lung Diseases/immunology,metabolism,pathology Peptides/pharmacology Pneumonia/immunology,metabolism,pathology Rabbits Time Factors
Chemicals
Anaphylatoxins Complement C5 Peptides
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Larsen G L
McCarthy K
Webster R O
Henson J
Henson P M
References (19)
19 references, click to expand
  1. Macrophage proteinase and inflammation: the production of chemotactic activity from the fifth complement by macrophage proteinase.
    J Immunol. 1972 Oct;109(4):896-8 PMID: 5074336
  2. Pathology of pulmonary oxygen toxicity.
    Am Rev Respir Dis. 1974 Dec;110(6 Pt 2):51-7 PMID: 4613233
  3. Evidence for the presence of components of the alternative (properdin) pathway of complement activation in respiratory secretions.
    J Immunol. 1976 Sep;117(3):900-3 PMID: 956659
  4. Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.
    J Clin Invest. 1977 Jan;59(1):165-75 PMID: 830661
  5. Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide prtions of human C5a.
    J Immunol. 1976 Nov;117(5 Pt 1):1688-94 PMID: 1002996
  6. Acute inflammation. A review.
    Am J Pathol. 1977 Jan;86(1):183-276 PMID: 64118
  7. Suppression of immune complex-induced inflammation by the chemotactic factor inactivator.
    J Clin Invest. 1977 May;59(5):951-8 PMID: 140184
  8. The in vitro effects of histamine and metiamide on neutrophil motility and their relationship to intracellular cyclic nucleotide levels.
    J Immunol. 1977 May;118(5):1690-6 PMID: 192799
  9. Immunopatholgenesis of hypersensitivity pneumonitis.
    J Allergy Clin Immunol. 1977 Jul;60(1):27-37 PMID: 141470
  10. Immune-complex disease in guinea pig lungs. I. Elicitation by aerosol challenge, suppression with cobra venom factor, and passive transfer with serum.
    Clin Immunol Immunopathol. 1977 Sep;8(2):213-24 PMID: 71224
  11. Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia.
    Am Rev Respir Dis. 1977 Oct;116(4):589-615 PMID: 921049
  12. Immunopathogenesis of hypersensitivity pneumonitis.
    Am Rev Respir Dis. 1977 Dec;116(6):1075-90 PMID: 412448
  13. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.
    J Immunol. 1978 Jan;120(1):109-15 PMID: 342601
  14. Lung and dermal vascular injury produced by preformed immune complexes.
    Am Rev Respir Dis. 1978 Mar;117(3):551-7 PMID: 629488
  15. Anaphylatoxins: C3a and C5a.
    Adv Immunol. 1978;26:1-53 PMID: 358800
  16. A modified method for chemotaxis under agarose.
    J Immunol Methods. 1979;25(4):337-53 PMID: 372445
  17. Acute inflammatory pulmonary reactions induced by chemotactic factors.
    Am J Pathol. 1979 Jul;96(1):71-83 PMID: 464027
  18. Complement fragments, alveolar macrophages, and alveolitis.
    Am J Pathol. 1979 Oct;97(1):93-110 PMID: 495697
  19. Chemotactic activity of C5ades Arg: evidence of a requirement for an anionic peptide 'helper factor' and inhibition by a cationic protein in serum from patients with systemic lupus erythematosus.
    Mol Immunol. 1980 Feb;17(2):163-9 PMID: 7393228
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
1980-07-00
Pages
179-92
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1903777
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com